BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 17, 2004
View Archived Issues
Eisai inlicenses clevudine from Bukwang Pharm
Read More
Chiron will not file BLA for Menjugate meningococcal C vaccine
Read More
MMV and GlaxoSmithKline to develop GW-844520X for malaria
Read More
Rigel and Merck & Co. partner on ubiquitin ligases research for cancer
Read More
Namenda sNDA for mild Alzheimer's disease accepted for review
Read More
AEOL-10150 enters phase I in ALS
Read More
Enrollment closes in Chinese Femprox study
Read More
Glufosfamide receives fast track status for pancreatic cancer
Read More
TPI-926 enters phase II for CNS disorder
Read More
TS-2037 demonstrates potent activity against MRSA
Read More
Novel lantibiotic has potent antimicrobial activity
Read More
Molecular cloaking technology enhances development of HIV-1 entry inhibitors
Read More
Novel von Willebrand factor antagonist prevents occlusive thrombus formation in vivo
Read More
Dimiracetam derivative for the treatment of neuropathic pain
Read More
Antiinflammatory compound for the treatment of acute ischemic stroke
Read More
Thyroid hormone binding protein may provide protection against Alzheimer's disease
Read More
New histone deacetylase inhibitors in early development at Syrrx
Read More
CCR2 receptor modulators described by Merck
Read More
Merck patent claims bradykinin B1 receptor antagonist
Read More
Three series of CGRP receptor antagonists claimed by Merck
Read More
A series of fused pyrrole compounds described in a patent
Read More
Activity of and resistance to antimalarial ferroquine evaluated
Read More
K-777 active against Cryptosporidium parvum in vitro and in vivo
Read More
Good safety profile found for HyCAMP in colorectal cancer
Read More
GW-501516 increases HDL-cholesterol levels in healthy volunteers
Read More
Six-year benefits of lopinavir/ritonavir therapy in HIV-infected patients
Read More
Uptake of DB-75 in Trypanosoma brucei brucei elucidated
Read More
Phase I/II data on the safety of PKC-412 plus imatinib mesylate in GIST
Read More
Antirestenotic activity of MS-275 measured in vitro, in vivo
Read More
Hemodynamic, renal effects of tolvaptan studied in congestive heart failure model
Read More
Antiatherosclerotic activity of S-1627 revealed in two species
Read More